Assignee
ALMIRALL SA
41 patents
Top patents by PatentIndex Score
US7750023B2Jul 6, 2010
Quinuclidine derivatives and medicinal compositions containing the same
ALMIRALL SA27 citations96
US7897617B2Mar 1, 2011
Quinuclidine derivatives and medicinal compositions containing the same
ALMIRALL SA21 citations95
US9333195B2May 10, 2016
Quinuclidine derivatives and medicinal compositions containing the same
ALMIRALL SA8 citations92
US9056100B2Jun 16, 2015
Quinuclidine derivatives and medicinal compositions containing the same
ALMIRALL SA9 citations92
US8802699B2Aug 12, 2014
Quinuclidine derivatives and medicinal compositions containing the same
ALMIRALL SA12 citations92
US7964615B2Jun 21, 2011
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor
ALMIRALL SA15 citations90
US10034867B2Jul 31, 2018
Quinuclidine derivatives and medicinal compositions containing the same
ALMIRALL SA2 citations84
US9687478B2Jun 27, 2017
Quinuclidine derivatives and medicinal compositions containing the same
ALMIRALL SA5 citations84
US7776879B2Aug 17, 2010
Quinuclidine carbamate derivatives and their use as M3 antagonists
ALMIRALL SA12 citations83
US9233108B2Jan 12, 2016
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
ALMIRALL SA9 citations82
USRE46417EMay 30, 2017
Quinuclidine derivatives and their use as muscarinic M3 receptor ligands
ALMIRALL SA4 citations80
US9562039B2Feb 7, 2017
Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities
ALMIRALL SA10 citations78
US7893087B2Feb 22, 2011
Quinuclidine derivatives and medicinal compositions containing the same
ALMIRALL SA5 citations74
US9757383B2Sep 12, 2017
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
ALMIRALL SA2 citations71
US9549934B2Jan 24, 2017
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
ALMIRALL SA2 citations71
US10005771B2Jun 26, 2018
Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
ALMIRALL SA2 citations70
US9643961B2May 9, 2017
Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities
ALMIRALL SA2 citations70
US10759793B2Sep 1, 2020
2-(pyrazolopyridin-3-yl)pyrimidine derivatives as JAK inhibitors
ALMIRALL SA3 citations69
US10434268B2Oct 8, 2019
Inhalation device for powdered drugs
ALMIRALL SA2 citations69
US9579316B2Feb 28, 2017
Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activities
ALMIRALL SA3 citations67
US9254262B2Feb 9, 2016
Dosage and formulation
ALMIRALL SA6 citations65
US10588895B2Mar 17, 2020
Quinuclidine derivatives and medicinal compositions containing the same
ALMIRALL SA0 citations63
US7879874B2Feb 1, 2011
Quinuclidine derivatives and medicinal compositions containing the same
ALMIRALL SA3 citations63
US8820321B2Sep 2, 2014
Storage system for powdered pharmaceuticals, and inhaler equipped with this system
ALMIRALL SA2 citations62
US8375940B2Feb 19, 2013
Storage system for powdered pharmaceuticals and inhaler equipped with this system
ALMIRALL SA1 citations62
US9907807B2Mar 6, 2018
Topical pharmaceutical compositions
ALMIRALL SA2 citations59
US8051851B2Nov 8, 2011
Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge system for use with this inhaler
ALMIRALL SA2 citations59
US9518050B2Dec 13, 2016
Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity
ALMIRALL SA2 citations57
US9737520B2Aug 22, 2017
Aclidinium for use in improving the quality of sleep in respiratory patients
ALMIRALL SA4 citations56
US11000517B2May 11, 2021
Dosage and formulation
ALMIRALL SA0 citations54
US10300072B2May 28, 2019
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
ALMIRALL SA0 citations51
US7954492B2Jun 7, 2011
Pharmaceutical powder cartridge, and inhaler equipped with same
ALMIRALL SA0 citations49
US10085974B2Oct 2, 2018
Dosage and formulation
ALMIRALL SA1 citations44
US9388189B2Jul 12, 2016
Pyrrolotriazinone derivatives as PI3K inhibitors
ALMIRALL SA1 citations41
US10828433B2Nov 10, 2020
Inhalation device for powdered drugs
ALMIRALL SA0 citations38
US10512740B2Dec 24, 2019
Inhalation device for powdered drugs
ALMIRALL SA0 citations38
US9346759B2May 24, 2016
Polymorphic crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, heminapadisytlate as agonist of the β2 adrenergic receptor
ALMIRALL SA0 citations38
US10214509B2Feb 26, 2019
Amino-substituted heterocyclic derivatives as sodium channel inhibitors
ALMIRALL SA0 citations37
US10456390B2Oct 29, 2019
Combinations comprising MABA compounds and corticosteroids
ALMIRALL SA0 citations36
US10173985B2Jan 8, 2019
Aminoindazole derivatives as sodium channel inhibitors
ALMIRALL SA0 citations33
US11602515B2Mar 14, 2023
Pharmaceutical compositions comprising dimethyl fumarate
ALMIRALL SA0 citations31